MRV Engenharia e Participações (MRVE3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 Oct, 2026Executive summary
High-quality land bank and inventory supported profitability and competitiveness; Minha Casa Minha Vida enhancements expanded purchasing power and supported demand.
Higher production and transfers, plus March-concentrated pre-sales, created a backlog expected to support 2Q26 transfers.
Asset sales and Brazilian development operations supported R$387m in total cash generation and progress on deleveraging.
Financial highlights
Net operating revenue was R$2.78bn, up from R$2.28bn year-over-year; MRV Real Estate Development net revenue was R$2.562bn, up 17.6%.
Gross margin reached 31.0%, up 1.4 p.p. year-over-year; reported gross profit was R$816.5m, versus R$654.1m.
Adjusted net profit was R$133m, up 640.4% year-over-year; reported net loss narrowed to R$76.3m from R$362.7m.
EBITDA reached R$476m, up 38.5% year-over-year; cash and cash equivalents were R$450.3m at quarter-end.
MRV Real Estate Development adjusted cash generation was R$128m; excluding portfolio sales, it was R$22.4m.
Outlook and guidance
Gross margin and net profit are expected to improve quarter-on-quarter as new vintages contribute more; margin expansion is expected to resume from 2Q26.
Higher sales and transfers are expected to strengthen cash generation; March pre-sales are expected to support higher 2Q26 transfers.
SG&A expenses are expected to decline as a percentage of net revenue; marketing expenses are expected to ease in subsequent quarters.
Urba expects further improvement in operational and financial indicators in 2026.
The US$6.7m Resia property-tax payment was an annual charge and is not expected to burden results in coming quarters.
Latest events from MRV Engenharia e Participações
- R$468.8 million in H1 cash generation and asset sales advanced deleveraging.MRVE3
Q2 2026 - Margin expansion, asset-light growth, and operational excellence drive improved results.MRVE3
Investor Day 2026 - Record margins and revenue growth, alongside cash pressures and Resia divestment.MRVE3
Q4 2025 - Q3 revenue and margins rose, while transfer delays constrained cash generation.MRVE3
Q3 2025 - Revenue and margins advanced, but transfer delays and Resia impairments weighed on cash and earnings.MRVE3
Q2 2025 - Asset-light strategy and divestments drive deleveraging and focus on high-return projects.MRVE3
Investor Update - Record pre-sales and cash generation support a strong outlook despite US losses.MRVE3
Q3 2024 - Record R$2.539B pre-sales and 34% new-sales margin; Resia cash outflow persisted.MRVE3
Q2 2024 - Record pre-sales and cash recovery; Resia pivots to an US$800 million deleveraging plan.MRVE3
Q4 2024